About Enhancer
| Enhancer ID: | E_01_0213 |
| Species: | Homo sapiens |
| Position : | chrKSHV:140000-164000   |
| Year: | 2024 |
| Title: | KSHV genome harbors both constitutive and lytically induced enhancers |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| PMID: | 38695538 |
| Tissue: | Lymphatic Endothelium |
| Standard Name: | Lymphatic Endothelium |
| Tissue Ontology ID: | UBERON:0000483 |
| Cell Source: | Human Kaposi sarcoma cell |
| CVCL ID: | CVCL_8250 |
| Cell Type: | Human Kaposi sarcoma cell |
| Experiment Type: | Enhancer activity assay; TF binding assay; Chromatin interaction assay; Functional perturbation assay |
| High Throughput Method: | FAIRE-seq; RNA-seq; ChIP-seq |
| Low Throughput Method: | CRISPRi (dCas9-KRAB-MeCP2); CRISPRa (dCas9-10xSunTag); Luciferase Reporter Assay; EMSA; RT-RT-qPCR; Western blot |
About Target Gene
| Target gene : | K2; ORF40; K1 |
About TF
| TF name : | RTA; LANA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer